Risperdal Consta Kit
Product Images NDC 50458-308

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Risperdal Consta (NDC 50458-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Risperdal 01)

Figure (Risperdal 01)
This is a description of a vial adapter with a Luer opening. It is used for a prefilled syringe and comes with a white plunger and rod collar. The adapter also includes colored cap and transparent needle protector. The package includes Terumo SurGuardĀ® 3 injection needles and a white diluent cap with a safety device. The needle length is 2 inches and it is used for microspheres.*
FDA Label Image

Figure (Risperdal 02)

FDA Label Image

Figure (Risperdal 03)

FDA Label Image

Figure (Risperdal 04)

FDA Label Image

Figure (Risperdal 05)

FDA Label Image

Figure (Risperdal 06)

FDA Label Image

Figure (Risperdal 07)

FDA Label Image

Figure (Risperdal 08)

Figure (Risperdal 08)
This appears to be a set of instructions for a medical device. The text suggests that there is a vial adapter involved, which should only be removed from a sterile blister when the user is ready to remove the white cap from the prefilled syringe. No further context is provided.*
FDA Label Image

Figure (Risperdal 09)

FDA Label Image

Figure (Risperdal 10)

FDA Label Image

Figure (Risperdal 11)

FDA Label Image

Figure (Risperdal 12)

FDA Label Image

Figure (Risperdal 13)

FDA Label Image

Figure (Risperdal 14)

FDA Label Image

Figure (Risperdal 15)

Figure (Risperdal 15)
This appears to be a short excerpt from instructions related to using a vial that will be under pressure. The user is advised to keep holding the plunger rod down with their thumb. It is not clear what the vial may contain, however.*
FDA Label Image

Figure (Risperdal 16)

FDA Label Image

Figure (Risperdal 17)

FDA Label Image

Figure (Risperdal 18)

FDA Label Image

Figure (Risperdal 19)

FDA Label Image

Figure (Risperdal 20)

FDA Label Image

Figure (Risperdal 21)

FDA Label Image

Figure (Risperdal 22)

FDA Label Image

Figure (Risperdal 23)

FDA Label Image

Figure (Risperdal 24)

FDA Label Image

Figure (Risperdal 25)

FDA Label Image

Figure (Risperdal 26)

FDA Label Image

Chemical Structure (Risperdal 27)

FDA Label Image

Principal Display Panel (12.5 mg Kit Carton)

Principal Display Panel (12.5 mg Kit Carton)
This is a set of instructions and information related to a dose pack of medication for intramuscular injection. The medication appears to be Risperidone and comes in a 125 mg vial along with other components. The instructions emphasize the importance of using all components of the dose pack and having a healthcare professional administer the injection.*
FDA Label Image

Principal Display Panel (25 mg Kit Carton)

FDA Label Image

Principal Display Panel (37.5 mg Kit Carton)

Principal Display Panel (37.5 mg Kit Carton)
This text appears to be a set of instructions for a medication, likely in the form of a Dose Pack. The medication in question appears to be Risperdal, in a prolonged-release injection form. The Dose Pack contents include a vial containing 375mg of the medication, a syringe containing 2mL, a 20 gauge needle, and a 2-inch needle. It is noted that the medication should only be administered via intramuscular injection by a healthcare professional. There are no further details on the condition or indications the medication is intended for treating.*
FDA Label Image

Principal Display Panel (50 mg Kit Carton)

Principal Display Panel (50 mg Kit Carton)
This is a description of a dose pack by Risperdal for a 50mg long-acting injectable solution. The contents include serrated syringe, 2-gauge UTW 1TS, a safety insertion needle, and a vial of risperidone. The dose pack is intended for use on deltoid or gluteal intramuscular injection only and instructions should be carefully read before use. A healthcare professional should administer each injection.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.